-NCI, Disparities Research Branch Director, Center for Cancer Health Equity, Nov 2023-present
-NCI, Program Director, Feb 2014-Present
-Human Genome Sciences (acquired by GSK), Scientist, Feb 2011-Jan 2013
-NCI, Postdoctoral fellow, May 2006-Jan 2011
(Source)
In her address at the National Comprehensive Cancer Network’s Oncology Policy Summit, Dr. Tiffany Wallace discussed the National Cancer Institute’s DEI efforts, including the NCI Health Equity Toolkit. Wallace said it has been “well received — we’ve had more than 60 sessions so far, with more than 500 participants,” and it’s not just for leadership, but “everyone who works at NCI — all levels of expertise and focus.”
What’s in this toolkit? 66 pages of examples, articles, questions to consider in cancer research—even “10 Simple Rules for Building an Antiracist Lab.”
(Source)
(Source)
Dr. Tiffany Wallace claims “[s]tructural racism has always been recognized,” at the National Cancer Institute, yet there are no solutions to such an historical problem.
That’s why she co-chairs a working group within NCI’s Equity Council, where they are focused on “advancing racial equity and social justice in cancer health disparities research, training and the NCI workforce. ”Maybe one of the reasons there still is no cure for cancer is that NCI is focused on curing things other than cancer.
“I do agree that we need to think bigger. Structural racism has always been recognized, but whether or not it’s been prioritized previously is something we’re looking at now,” said Tiffany Wallace, co-chair of Working Group 1, and a program director in the Office of the Director of NCI’s Center to Reduce Cancer Health Disparities. “You mentioned partnerships, I think that that’s going to be key in trying to address this huge issue.
“I also don’t think I have a solution, but I think we were recognizing the problem and we see what’s ahead,” Wallace said. “And this is what our working groups are strategizing on to figure out more.”